Leadership Team

Larry Heaton

Chief Executive Officer

Larry has more than 35 years of executive leadership and operations experience from the therapeutic, medical device and biotechnology industries, with an extensive focus on business and product development and commercialization at both large cap and early-stage medical device companies . 

Most recently, Larry was President, Chief Executive Officer and Director of Flowonix, Inc., a privately held company marketing implantable drug-delivery systems for the management of pain and spasticity. Prior to that, he was President, Chief Executive Officer and Director of Cardiox Corporation, a privately held company that developed and marketed drug-device combination products for the structural heart and liver diagnostics markets. He also has served as President, Chief Executive Officer and Chairman of the board of Vioptix Inc., a privately held company in the tissue oximetry field, President, Chief Executive Officer and Director of Curon Medical, Inc., a public company marketing products for the treatment of gastrointestinal disorders, and President, Chief Executive Officer and Director of Response Genetics, Inc., an applied genomics start-up firm providing gene expression services in the oncology market.

His earlier career spanned 18 years at United States Surgical Corporation (USSC), a leading manufacturer of innovative wound closure and advanced surgical products, serving in roles of increasing responsibility in Sales, Marketing and General Management. His career at USSC culminated in his serving as President and Chief Operating Officer of USSC from 1998 through 2000.

Larry was awarded a Bachelor of Arts degree from Eastern Illinois University, and is an inventor on several U.S. patents. He has served as a member of the board of several international medical societies and foundations, including the MITAC Board for the commercialization of NASA technology via partnerships with the medical industry.

Ann Cotter, CPA

Chief Financial Officer

Ann has primary responsibility for planning, implementation, and management of Zomedica’s finance activities, including business planning, budgeting, forecasting and negotiations. She  served as the Company’s Vice President of Finance from August 2018 until October 2020, when she was promoted to her current role. 

Throughout her career, Ann has held various consulting, controllership and Chief Financial Officer roles for both private and publicly held companies and has public accounting experience in both audit and tax services. She served as Chief Financial Officer of American Fence Company, a fence rental, installation and manufacturing company, from April 2018 through August 2018. She has also served as Corporate Controller of ProMotion Technology Group, a digital solutions provider, from September 2014 through August 2017. Ann holds a Master of Taxation from Capital University Law School and a Bachelor of Arts in Economics and Spanish from Capital University. She is a Certified Public Accountant, licensed in Ohio since 1996.

Tony Blair

Executive Vice President, Operations                                                                                      

Tony recently joined Zomedica in January 2022. Prior to joining Zomedica he was a principal founder of BGA Mfg. Services LLC a manufacturing and operations consulting organization. Tony was COO of Cardiox Corporation from 2012 through 2016, a privately held company that developed, manufactured and marketed drug-device combination products for the structural heart and liver markets. Tony has more than 30 years of operations leadership experience in the medical device and pharmaceutical industries.

Before joining Cardiox in 2012, Tony served as VP of Manufacturing for Devicor Medical Products, the parent corporation of Mammotome, a global company dedicated to acquiring and growing healthcare companies which subsequently acquired Neoprobe, a public company, where he served as Vice President, of Manufacturing Operations.  

Prior to Neoprobe, Tony served as Vice President, Manufacturing Operations of Enpath Medical, from 2002 to 2004 which acquired Biomec Cardiovascular, Inc.  

From 1998 through 2001, Tony led the manufacturing efforts at Astro Instrumentation, a medical device contract manufacturer. He was part of the leadership of the company from initial start-up in 1998.  Prior to Astro, he spent 10 years at Ciba-Corning Diagnostics (now Bayer), in various managerial capacities including Operations Manager, Materials Manager, Purchasing Manager, and Production Supervisor. Before that, he was employed by Bailey Controls and held various positions increasing in responsibility in purchasing and industrial engineering. Mr. Blair started his career at Fisher Body a division of General Motors in production supervision.  

He holds a Bachelors degree in Business Administration from Cleveland State University.

Greg Blair, MBA

Vice President of Business Development & Strategic Planning

Greg is a dynamic life sciences leader with experience across business development, commercial, product development and finance roles. He is responsible for building and executing an external innovation strategy to maximize shareholder value. 

Greg’s focus is on creating value-added partnerships and acquiring differentiated technology that helps Zomedica’s customers thrive in practice and supports their mission to enhance the veterinary care experience for pets and pet parents. 

Greg joined Zomedica from Elanco Animal Health, where he was known for his collaborative approach to creating strategic alliances that built trust and confidence with partners across the industry.  While at Elanco, Greg delivered multiple successful transactions, including acquisitions, divestitures, strategic alliances, equity investments and licensing transactions.

He has dedicated his career to leading teams that deliver innovative solutions for customers with companies such as Johnson and Johnson, Intuitive Surgical and Enteromedics. Greg’s passion for innovation and pursuit of technologies that solve unmet needs, improve clinicians’ practices and enrich patient lives led him to launch numerous innovative products throughout his career. 

Outside of work, Greg enjoys spending quality time with his wife and young son, as well as their Beauceron, Poscoe. He is a private pilot, and the family enjoys taking trips around the eastern US to anywhere with a beach and warm weather.

Adrian Lock

Vice President and General Manager                                                                                      

Adrian joined the Zomedica leadership team in October, 2021 when the company he founded in 2009, Pulse Veterinary Technologies, LLC (“PulseVet”) was acquired.  He brings over 30 years of human and veterinary healthcare and biotechnology sales, marketing, and executive leadership experience to the organization.

Prior to PulseVet, Adrian was Vice-President of Sales and Marketing with Sanuwave, where he devoted his energy and resources to developing and commercializing shock wave technology. While at Sanuwave he took over the veterinary division, allowing him to combine his training and background with his lifelong passion for animals. In 2009 the veterinary division of Sanuwave split to form PulseVet.  As Director of Global Marketing with CryoLife, he launched BioGlue ® Surgical Adhesive in 2001. BioGlue is a life-saving product now recognized as the leading surgical adhesive in worldwide clinical use for indications in cardiovascular, neurological, and soft tissue surgeries. 

Prior to starting his healthcare career, Adrian served in the US Navy as a nuclear trained submarine officer, where he was awarded a Navy Achievement Medal and a Navy Commendation Medal for his service aboard 2 submarines, USS Flying Fish (SSN673), USS Scranton (SSN756), and as a Watch Officer at ComSubLant. 

Adrian holds a BS degree in Engineering Science from Vanderbilt University, which he attended on a Navy ROTC scholarship. 

In his free time Adrian enjoys playing guitar, fitness/outdoor activities, and spending time with his wife, Rhonda, four daughters, two granddaughters, two dogs, and cat.

Nicole Westfall

Vice President of Marketing                                                                                     

Nicole brings more than 25 years of experience in marketing, sales and communications covering the gamut of marketing arenas from corporate communications to product management to event planning to media. Passionate about animal health, she has spent the last decade working with various manufacturers to spread the word about their products and services.

Most recently, Nicole was the Senior Director of Sales and Marketing for Assisi Animal Health, a privately held company specializing in TPEMF medical devices to help pets live better pain and anxiety free lives. She has, also, served as Associate Director of Marketing for PRN Pharmacal with a focus on marketing their flagship product, PROIN, along with their line of nutraceuticals for inflammation and pain.

Nicole spent her earlier career in various forms of the marketing and media realm. She successfully ran her own marketing/advertising agency for 15 years, but also spent time on the media side of the business. She has been published in over 100 publications as well as worked in various positions in television and radio.


Ms. Westfall holds a Bachelor’s Degree in Communications from Baylor University and an MBA in International Business from University of Texas, Arlington.

Kristin Domanski

Vice President of Human Resources                                                                                   

Kristin joined the Company on January 24, 2022, as its Vice President, Human Resources. Kristin holds a B.S. in Leadership Studies and a M.S. in Human Resources Administration from Central Michigan University, and brings 30 years of HR experience to Zomedica. Her career includes HR roles in banking, consulting, life sciences, and healthcare.

Most recently she was VP of Human Resources for Nexcare Wellbridge Senior Living, a large skilled nursing organization in Michigan, and before that was Director of HR, North America, for Enzo Life Sciences, with locations in Michigan and New York. Kristin’s breadth of experience across all facets of Human Resources, and success in building HR systems and programs, will be focused on the goal of developing a best-in-class HR experience for Zomedica and all acquired entities. 


Evan St. Peter, MBA

Vice President of Technology Innovation

Evan joined Zomedica in September of 2018 to lead the development of a cloud-based data platform to capture data from Zomedica’s diagnostic devices. This platform is known as MyZomedicaTM today. He now leads the company’s technology innovation for both Zomedica’s customer facing digital technology as well as Zomedica’s internal technology needs.

Prior to joining Zomedica, Evan was part of the Connected Care team within Stryker’s Medical and Surgical Division, where he helped lead delivery of Stryker’s customer facing IoT and machine learning application called Smart Equipment Management. During his time at Stryker, he was responsible for leading Agile application development across onshore and offshore development teams as well as the statistical validation of supervised machine learning models to identify surgical devices that would benefit from preventative maintenance. In addition to his time at Stryker, Evan brings operations and enterprise IT experience from his time at MPI Research, where he held roles of increasing responsibility throughout his career there.

Evan holds a Bachelor of Science in Biology from Northern Michigan University and a Master of Business Administration from Western Michigan University. He is the father of two boys. He and his wife enjoy family camping and home DIY, and he is an avid cyclist.


Ashley Wood, PhD

Senior Director of Research and Development 

Ashley joined Zomedica in 2019 to facilitate the development of BAW technology for use in veterinary medicine. She now leads the company’s research and development activities. Ashley’s expertise is in the areas of molecular biology, cell biology, imaging techniques and biochemistry.

Prior to her current role, Ashley was part of the R&D group at Swift Biosciences, where she was responsible for creating market viable products as the lead scientist in the advancement of next generation sequencing assays. Her responsibilities included assay development, bioinformatic analysis, and transfer to manufacturing.

Ashley also served as a research assistant professor and completed as postdoctoral research fellowship (awarded by the American Cancer Society) in the Cell & Molecular Biology department at Northwestern University’s Feinberg School of Medicine. She has co-authored several papers that have appeared in industry-prominent journals.

Ashley graduated with honors from Duke University with a degree in biochemistry, and earned a PhD in molecular biology from Johns Hopkins University. She is the mother of two young boys, and when she’s not transporting them to hockey, baseball, or other activities, she enjoys cooking, running, and spending time outdoors.